Review




Structured Review

Charles River Laboratories pc-9 ero1a knockout cell line
High expression of <t>ERO1A</t> is associated with poor prognosis in all-NSCLC( A ), when considering squamous ( B ) and adenocarcinoma histology ( C ) and when accounting for EGFR mutation status ( D , E ). ERO1A quartiles are based on expression in all-NSCLC patients and were consistently applied across all subtypes of NSCLC.
Pc 9 Ero1a Knockout Cell Line, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pc-9 ero1a knockout cell line/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
pc-9 ero1a knockout cell line - by Bioz Stars, 2026-03
90/100 stars

Images

1) Product Images from "ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer"

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

Journal: NPJ Precision Oncology

doi: 10.1038/s41698-024-00736-1

High expression of ERO1A is associated with poor prognosis in all-NSCLC( A ), when considering squamous ( B ) and adenocarcinoma histology ( C ) and when accounting for EGFR mutation status ( D , E ). ERO1A quartiles are based on expression in all-NSCLC patients and were consistently applied across all subtypes of NSCLC.
Figure Legend Snippet: High expression of ERO1A is associated with poor prognosis in all-NSCLC( A ), when considering squamous ( B ) and adenocarcinoma histology ( C ) and when accounting for EGFR mutation status ( D , E ). ERO1A quartiles are based on expression in all-NSCLC patients and were consistently applied across all subtypes of NSCLC.

Techniques Used: Expressing, Mutagenesis

ERO1A quartile cutoffs were determined based on the expression of ERO1A in EGFRmt-LUAD. A Patients with tumors expressing high ERO1A levels have increased survival. B Molecular alterations associated with ERO1A expression prevalent in either cohort at ≥2% and statistically significantly different are shown in the table. C Molecular alterations with a prevalence difference of at least 5% between the cohorts were incorporated as co-variates in a complete-case multivariate analysis. High ERO1A expression and TP53 mutations were independently associated with poor OS in EGFRmt-LUAD ( n = 960).
Figure Legend Snippet: ERO1A quartile cutoffs were determined based on the expression of ERO1A in EGFRmt-LUAD. A Patients with tumors expressing high ERO1A levels have increased survival. B Molecular alterations associated with ERO1A expression prevalent in either cohort at ≥2% and statistically significantly different are shown in the table. C Molecular alterations with a prevalence difference of at least 5% between the cohorts were incorporated as co-variates in a complete-case multivariate analysis. High ERO1A expression and TP53 mutations were independently associated with poor OS in EGFRmt-LUAD ( n = 960).

Techniques Used: Expressing

High expression of ERO1A was associated with an enrichment of a number of Hallmark Pathways as revealed by GSEA. The second most significant pathway was associated with regulating protein secretion ( A ). The association of ERO1A expression was established with the expression of genes involved in Hallmark protein secretion pathway. Genes were sorted based on their Spearman correlation with ERO1A and are listed to the right side of the heatmap ( B ). Subset of genes involved in vesicle trafficking from ER to Golgi as well as regulation of exosomes were investigated and observed to be significantly enriched in ERO1A -Q4 tumors ( C ). Correlation between ERO1A and levels of other proteins downloaded from CPTAC, a publicly available lung adenocarcinoma tumor proteomics dataset, were analyzed using LinkedOmics ( http://linkedomics.org/data_download/CPTAC-LUAD/ ) ( D ). 7 out of 28 targets with highest correlation to ERO1A levels are extracellular matrix proteins ( E ).
Figure Legend Snippet: High expression of ERO1A was associated with an enrichment of a number of Hallmark Pathways as revealed by GSEA. The second most significant pathway was associated with regulating protein secretion ( A ). The association of ERO1A expression was established with the expression of genes involved in Hallmark protein secretion pathway. Genes were sorted based on their Spearman correlation with ERO1A and are listed to the right side of the heatmap ( B ). Subset of genes involved in vesicle trafficking from ER to Golgi as well as regulation of exosomes were investigated and observed to be significantly enriched in ERO1A -Q4 tumors ( C ). Correlation between ERO1A and levels of other proteins downloaded from CPTAC, a publicly available lung adenocarcinoma tumor proteomics dataset, were analyzed using LinkedOmics ( http://linkedomics.org/data_download/CPTAC-LUAD/ ) ( D ). 7 out of 28 targets with highest correlation to ERO1A levels are extracellular matrix proteins ( E ).

Techniques Used: Expressing

Shown is a representative image demonstrating CRISPR deletion of ERO1A in PC-9 and HCC006 cell line. ERO1B expression levels do not compensate for loss of ERO1A. Representative western blots demonstrate that ERO1A KO does not affect total levels of EGFR or p-EGFR in two EGFR MUT -NSCLC cell lines ( A ). ERO1A KO cells form smaller number of colonies in soft agar and on tissue culture plates. Representative fields of view from one independent experiment are shown. *** p = 0.0004 by one-way ANOVA, * p = 0.0111 by repeated measures ANOVA, n = 3–4 independent experiments performed in triplicates ( B , C ). ERO1A KO clones reveal a decrease in total tumor sphere formation in both PC-9 and HCC4006 cell lines. Representative fields of view from one independent experiment are shown. Shown is the means of 3-4 independent experiments performed in triplicates. Numbers are mean ± SEM. **** p < 0.0001, ** p = 0.0072, * p < 0.05; Dunnett’s multiple comparisons test following one-way ANOVA ( D – E ).
Figure Legend Snippet: Shown is a representative image demonstrating CRISPR deletion of ERO1A in PC-9 and HCC006 cell line. ERO1B expression levels do not compensate for loss of ERO1A. Representative western blots demonstrate that ERO1A KO does not affect total levels of EGFR or p-EGFR in two EGFR MUT -NSCLC cell lines ( A ). ERO1A KO cells form smaller number of colonies in soft agar and on tissue culture plates. Representative fields of view from one independent experiment are shown. *** p = 0.0004 by one-way ANOVA, * p = 0.0111 by repeated measures ANOVA, n = 3–4 independent experiments performed in triplicates ( B , C ). ERO1A KO clones reveal a decrease in total tumor sphere formation in both PC-9 and HCC4006 cell lines. Representative fields of view from one independent experiment are shown. Shown is the means of 3-4 independent experiments performed in triplicates. Numbers are mean ± SEM. **** p < 0.0001, ** p = 0.0072, * p < 0.05; Dunnett’s multiple comparisons test following one-way ANOVA ( D – E ).

Techniques Used: CRISPR, Expressing, Western Blot, Clone Assay

Levels of LAMC2 and LOXL2 are dramatically reduced in conditioned medium collected from ERO1A KO cells. Representative western blots on whole cell lysates and conditioned media in PC-9 cell line are shown ( A ). Concentration of LAMC2 secreted into conditioned media by ERO1A KO cell lines is reduced compared to control cells. ELISA was performed in triplicate and the average ± S.D. of n = 3 combined results are shown. **** p < 0.0001; Dunnett’s multiple comparisons test following one-way ANOVA ( B – C ). Representative images of immunofluorescence staining for LOXL2 and LAMC2 in HCC4006 spheroids, scale bar - 50 µm ( D – E ). Quantification of LOXL2 and LAMC2 immunofluorescent staining in control and ERO1A KO HCC4006 cells cultured as tumor spheres. * p = 0.0209 by two-tailed unpaired t -test, n = 5, experiment was repeated 3 times. ns – not significant ( F ).
Figure Legend Snippet: Levels of LAMC2 and LOXL2 are dramatically reduced in conditioned medium collected from ERO1A KO cells. Representative western blots on whole cell lysates and conditioned media in PC-9 cell line are shown ( A ). Concentration of LAMC2 secreted into conditioned media by ERO1A KO cell lines is reduced compared to control cells. ELISA was performed in triplicate and the average ± S.D. of n = 3 combined results are shown. **** p < 0.0001; Dunnett’s multiple comparisons test following one-way ANOVA ( B – C ). Representative images of immunofluorescence staining for LOXL2 and LAMC2 in HCC4006 spheroids, scale bar - 50 µm ( D – E ). Quantification of LOXL2 and LAMC2 immunofluorescent staining in control and ERO1A KO HCC4006 cells cultured as tumor spheres. * p = 0.0209 by two-tailed unpaired t -test, n = 5, experiment was repeated 3 times. ns – not significant ( F ).

Techniques Used: Western Blot, Concentration Assay, Control, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Staining, Cell Culture, Two Tailed Test

Soft agar colony formation assay using regular non-conditioned medium (Normal), medium conditioned by control cells (Conditioned) and conditioned medium from control cells after heat denaturation (Heat denatured), **** p < 0.0001, two-way ANOVA followed by Sidak’s multiple comparisons test, n = 3 ( A ). Conditioned medium generated by ERO1A KO cells does not rescue colony formation abilities of ERO1A KO cells ( B ). Representative immunoblot showing level of LAMC2 and LOXL2 knockdown in PC-9 cells. LAMC2 or LOXL2 knockdown dramatically decrease levels of secreted LAMC2 and LOXL2, accordingly ( C ). Conditioned medium generated by sh LOXL2 and sh LAMC2 PC-9 cells partially rescue colony formation abilities of ERO1A KO cells in soft agar assay. GFP—empty vector control. Data are means ± SD. **** p < 0.0001, Tukey’s multiple comparisons test following two-way ANOVA. ns – not significant ( D ).
Figure Legend Snippet: Soft agar colony formation assay using regular non-conditioned medium (Normal), medium conditioned by control cells (Conditioned) and conditioned medium from control cells after heat denaturation (Heat denatured), **** p < 0.0001, two-way ANOVA followed by Sidak’s multiple comparisons test, n = 3 ( A ). Conditioned medium generated by ERO1A KO cells does not rescue colony formation abilities of ERO1A KO cells ( B ). Representative immunoblot showing level of LAMC2 and LOXL2 knockdown in PC-9 cells. LAMC2 or LOXL2 knockdown dramatically decrease levels of secreted LAMC2 and LOXL2, accordingly ( C ). Conditioned medium generated by sh LOXL2 and sh LAMC2 PC-9 cells partially rescue colony formation abilities of ERO1A KO cells in soft agar assay. GFP—empty vector control. Data are means ± SD. **** p < 0.0001, Tukey’s multiple comparisons test following two-way ANOVA. ns – not significant ( D ).

Techniques Used: Soft Agar Assay, Control, Generated, Western Blot, Knockdown, Plasmid Preparation

Picture of tumors formed and H & E staining from the lungs of ERO1A replete and KO mice. H & E was performed on 5 random lungs from each group selected by a random number generator and tumor margins quantified using ImageJ ( A , B ). Each data point represents the average on three sections from each mouse. * p = 0.0110, unpaired t -test ( C ). Kaplan–Meier curve showing that ERO1A KO increased overall survival compared to the control group. p = 0.0064, log-rank (Mantel-Cox) test ( D ).
Figure Legend Snippet: Picture of tumors formed and H & E staining from the lungs of ERO1A replete and KO mice. H & E was performed on 5 random lungs from each group selected by a random number generator and tumor margins quantified using ImageJ ( A , B ). Each data point represents the average on three sections from each mouse. * p = 0.0110, unpaired t -test ( C ). Kaplan–Meier curve showing that ERO1A KO increased overall survival compared to the control group. p = 0.0064, log-rank (Mantel-Cox) test ( D ).

Techniques Used: Staining, Control

Antibodies used for Western blot experiments
Figure Legend Snippet: Antibodies used for Western blot experiments

Techniques Used: Western Blot



Similar Products

90
Charles River Laboratories pc-9 ero1a knockout cell line
High expression of <t>ERO1A</t> is associated with poor prognosis in all-NSCLC( A ), when considering squamous ( B ) and adenocarcinoma histology ( C ) and when accounting for EGFR mutation status ( D , E ). ERO1A quartiles are based on expression in all-NSCLC patients and were consistently applied across all subtypes of NSCLC.
Pc 9 Ero1a Knockout Cell Line, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pc-9 ero1a knockout cell line/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
pc-9 ero1a knockout cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


High expression of ERO1A is associated with poor prognosis in all-NSCLC( A ), when considering squamous ( B ) and adenocarcinoma histology ( C ) and when accounting for EGFR mutation status ( D , E ). ERO1A quartiles are based on expression in all-NSCLC patients and were consistently applied across all subtypes of NSCLC.

Journal: NPJ Precision Oncology

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

doi: 10.1038/s41698-024-00736-1

Figure Lengend Snippet: High expression of ERO1A is associated with poor prognosis in all-NSCLC( A ), when considering squamous ( B ) and adenocarcinoma histology ( C ) and when accounting for EGFR mutation status ( D , E ). ERO1A quartiles are based on expression in all-NSCLC patients and were consistently applied across all subtypes of NSCLC.

Article Snippet: 2 million of either PC-9 control or PC-9 ERO1A knockout cell line were injected via tail vein into SCID-Beige mice Charles River Laboratories.

Techniques: Expressing, Mutagenesis

ERO1A quartile cutoffs were determined based on the expression of ERO1A in EGFRmt-LUAD. A Patients with tumors expressing high ERO1A levels have increased survival. B Molecular alterations associated with ERO1A expression prevalent in either cohort at ≥2% and statistically significantly different are shown in the table. C Molecular alterations with a prevalence difference of at least 5% between the cohorts were incorporated as co-variates in a complete-case multivariate analysis. High ERO1A expression and TP53 mutations were independently associated with poor OS in EGFRmt-LUAD ( n = 960).

Journal: NPJ Precision Oncology

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

doi: 10.1038/s41698-024-00736-1

Figure Lengend Snippet: ERO1A quartile cutoffs were determined based on the expression of ERO1A in EGFRmt-LUAD. A Patients with tumors expressing high ERO1A levels have increased survival. B Molecular alterations associated with ERO1A expression prevalent in either cohort at ≥2% and statistically significantly different are shown in the table. C Molecular alterations with a prevalence difference of at least 5% between the cohorts were incorporated as co-variates in a complete-case multivariate analysis. High ERO1A expression and TP53 mutations were independently associated with poor OS in EGFRmt-LUAD ( n = 960).

Article Snippet: 2 million of either PC-9 control or PC-9 ERO1A knockout cell line were injected via tail vein into SCID-Beige mice Charles River Laboratories.

Techniques: Expressing

High expression of ERO1A was associated with an enrichment of a number of Hallmark Pathways as revealed by GSEA. The second most significant pathway was associated with regulating protein secretion ( A ). The association of ERO1A expression was established with the expression of genes involved in Hallmark protein secretion pathway. Genes were sorted based on their Spearman correlation with ERO1A and are listed to the right side of the heatmap ( B ). Subset of genes involved in vesicle trafficking from ER to Golgi as well as regulation of exosomes were investigated and observed to be significantly enriched in ERO1A -Q4 tumors ( C ). Correlation between ERO1A and levels of other proteins downloaded from CPTAC, a publicly available lung adenocarcinoma tumor proteomics dataset, were analyzed using LinkedOmics ( http://linkedomics.org/data_download/CPTAC-LUAD/ ) ( D ). 7 out of 28 targets with highest correlation to ERO1A levels are extracellular matrix proteins ( E ).

Journal: NPJ Precision Oncology

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

doi: 10.1038/s41698-024-00736-1

Figure Lengend Snippet: High expression of ERO1A was associated with an enrichment of a number of Hallmark Pathways as revealed by GSEA. The second most significant pathway was associated with regulating protein secretion ( A ). The association of ERO1A expression was established with the expression of genes involved in Hallmark protein secretion pathway. Genes were sorted based on their Spearman correlation with ERO1A and are listed to the right side of the heatmap ( B ). Subset of genes involved in vesicle trafficking from ER to Golgi as well as regulation of exosomes were investigated and observed to be significantly enriched in ERO1A -Q4 tumors ( C ). Correlation between ERO1A and levels of other proteins downloaded from CPTAC, a publicly available lung adenocarcinoma tumor proteomics dataset, were analyzed using LinkedOmics ( http://linkedomics.org/data_download/CPTAC-LUAD/ ) ( D ). 7 out of 28 targets with highest correlation to ERO1A levels are extracellular matrix proteins ( E ).

Article Snippet: 2 million of either PC-9 control or PC-9 ERO1A knockout cell line were injected via tail vein into SCID-Beige mice Charles River Laboratories.

Techniques: Expressing

Shown is a representative image demonstrating CRISPR deletion of ERO1A in PC-9 and HCC006 cell line. ERO1B expression levels do not compensate for loss of ERO1A. Representative western blots demonstrate that ERO1A KO does not affect total levels of EGFR or p-EGFR in two EGFR MUT -NSCLC cell lines ( A ). ERO1A KO cells form smaller number of colonies in soft agar and on tissue culture plates. Representative fields of view from one independent experiment are shown. *** p = 0.0004 by one-way ANOVA, * p = 0.0111 by repeated measures ANOVA, n = 3–4 independent experiments performed in triplicates ( B , C ). ERO1A KO clones reveal a decrease in total tumor sphere formation in both PC-9 and HCC4006 cell lines. Representative fields of view from one independent experiment are shown. Shown is the means of 3-4 independent experiments performed in triplicates. Numbers are mean ± SEM. **** p < 0.0001, ** p = 0.0072, * p < 0.05; Dunnett’s multiple comparisons test following one-way ANOVA ( D – E ).

Journal: NPJ Precision Oncology

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

doi: 10.1038/s41698-024-00736-1

Figure Lengend Snippet: Shown is a representative image demonstrating CRISPR deletion of ERO1A in PC-9 and HCC006 cell line. ERO1B expression levels do not compensate for loss of ERO1A. Representative western blots demonstrate that ERO1A KO does not affect total levels of EGFR or p-EGFR in two EGFR MUT -NSCLC cell lines ( A ). ERO1A KO cells form smaller number of colonies in soft agar and on tissue culture plates. Representative fields of view from one independent experiment are shown. *** p = 0.0004 by one-way ANOVA, * p = 0.0111 by repeated measures ANOVA, n = 3–4 independent experiments performed in triplicates ( B , C ). ERO1A KO clones reveal a decrease in total tumor sphere formation in both PC-9 and HCC4006 cell lines. Representative fields of view from one independent experiment are shown. Shown is the means of 3-4 independent experiments performed in triplicates. Numbers are mean ± SEM. **** p < 0.0001, ** p = 0.0072, * p < 0.05; Dunnett’s multiple comparisons test following one-way ANOVA ( D – E ).

Article Snippet: 2 million of either PC-9 control or PC-9 ERO1A knockout cell line were injected via tail vein into SCID-Beige mice Charles River Laboratories.

Techniques: CRISPR, Expressing, Western Blot, Clone Assay

Levels of LAMC2 and LOXL2 are dramatically reduced in conditioned medium collected from ERO1A KO cells. Representative western blots on whole cell lysates and conditioned media in PC-9 cell line are shown ( A ). Concentration of LAMC2 secreted into conditioned media by ERO1A KO cell lines is reduced compared to control cells. ELISA was performed in triplicate and the average ± S.D. of n = 3 combined results are shown. **** p < 0.0001; Dunnett’s multiple comparisons test following one-way ANOVA ( B – C ). Representative images of immunofluorescence staining for LOXL2 and LAMC2 in HCC4006 spheroids, scale bar - 50 µm ( D – E ). Quantification of LOXL2 and LAMC2 immunofluorescent staining in control and ERO1A KO HCC4006 cells cultured as tumor spheres. * p = 0.0209 by two-tailed unpaired t -test, n = 5, experiment was repeated 3 times. ns – not significant ( F ).

Journal: NPJ Precision Oncology

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

doi: 10.1038/s41698-024-00736-1

Figure Lengend Snippet: Levels of LAMC2 and LOXL2 are dramatically reduced in conditioned medium collected from ERO1A KO cells. Representative western blots on whole cell lysates and conditioned media in PC-9 cell line are shown ( A ). Concentration of LAMC2 secreted into conditioned media by ERO1A KO cell lines is reduced compared to control cells. ELISA was performed in triplicate and the average ± S.D. of n = 3 combined results are shown. **** p < 0.0001; Dunnett’s multiple comparisons test following one-way ANOVA ( B – C ). Representative images of immunofluorescence staining for LOXL2 and LAMC2 in HCC4006 spheroids, scale bar - 50 µm ( D – E ). Quantification of LOXL2 and LAMC2 immunofluorescent staining in control and ERO1A KO HCC4006 cells cultured as tumor spheres. * p = 0.0209 by two-tailed unpaired t -test, n = 5, experiment was repeated 3 times. ns – not significant ( F ).

Article Snippet: 2 million of either PC-9 control or PC-9 ERO1A knockout cell line were injected via tail vein into SCID-Beige mice Charles River Laboratories.

Techniques: Western Blot, Concentration Assay, Control, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Staining, Cell Culture, Two Tailed Test

Soft agar colony formation assay using regular non-conditioned medium (Normal), medium conditioned by control cells (Conditioned) and conditioned medium from control cells after heat denaturation (Heat denatured), **** p < 0.0001, two-way ANOVA followed by Sidak’s multiple comparisons test, n = 3 ( A ). Conditioned medium generated by ERO1A KO cells does not rescue colony formation abilities of ERO1A KO cells ( B ). Representative immunoblot showing level of LAMC2 and LOXL2 knockdown in PC-9 cells. LAMC2 or LOXL2 knockdown dramatically decrease levels of secreted LAMC2 and LOXL2, accordingly ( C ). Conditioned medium generated by sh LOXL2 and sh LAMC2 PC-9 cells partially rescue colony formation abilities of ERO1A KO cells in soft agar assay. GFP—empty vector control. Data are means ± SD. **** p < 0.0001, Tukey’s multiple comparisons test following two-way ANOVA. ns – not significant ( D ).

Journal: NPJ Precision Oncology

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

doi: 10.1038/s41698-024-00736-1

Figure Lengend Snippet: Soft agar colony formation assay using regular non-conditioned medium (Normal), medium conditioned by control cells (Conditioned) and conditioned medium from control cells after heat denaturation (Heat denatured), **** p < 0.0001, two-way ANOVA followed by Sidak’s multiple comparisons test, n = 3 ( A ). Conditioned medium generated by ERO1A KO cells does not rescue colony formation abilities of ERO1A KO cells ( B ). Representative immunoblot showing level of LAMC2 and LOXL2 knockdown in PC-9 cells. LAMC2 or LOXL2 knockdown dramatically decrease levels of secreted LAMC2 and LOXL2, accordingly ( C ). Conditioned medium generated by sh LOXL2 and sh LAMC2 PC-9 cells partially rescue colony formation abilities of ERO1A KO cells in soft agar assay. GFP—empty vector control. Data are means ± SD. **** p < 0.0001, Tukey’s multiple comparisons test following two-way ANOVA. ns – not significant ( D ).

Article Snippet: 2 million of either PC-9 control or PC-9 ERO1A knockout cell line were injected via tail vein into SCID-Beige mice Charles River Laboratories.

Techniques: Soft Agar Assay, Control, Generated, Western Blot, Knockdown, Plasmid Preparation

Picture of tumors formed and H & E staining from the lungs of ERO1A replete and KO mice. H & E was performed on 5 random lungs from each group selected by a random number generator and tumor margins quantified using ImageJ ( A , B ). Each data point represents the average on three sections from each mouse. * p = 0.0110, unpaired t -test ( C ). Kaplan–Meier curve showing that ERO1A KO increased overall survival compared to the control group. p = 0.0064, log-rank (Mantel-Cox) test ( D ).

Journal: NPJ Precision Oncology

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

doi: 10.1038/s41698-024-00736-1

Figure Lengend Snippet: Picture of tumors formed and H & E staining from the lungs of ERO1A replete and KO mice. H & E was performed on 5 random lungs from each group selected by a random number generator and tumor margins quantified using ImageJ ( A , B ). Each data point represents the average on three sections from each mouse. * p = 0.0110, unpaired t -test ( C ). Kaplan–Meier curve showing that ERO1A KO increased overall survival compared to the control group. p = 0.0064, log-rank (Mantel-Cox) test ( D ).

Article Snippet: 2 million of either PC-9 control or PC-9 ERO1A knockout cell line were injected via tail vein into SCID-Beige mice Charles River Laboratories.

Techniques: Staining, Control

Antibodies used for Western blot experiments

Journal: NPJ Precision Oncology

Article Title: ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer

doi: 10.1038/s41698-024-00736-1

Figure Lengend Snippet: Antibodies used for Western blot experiments

Article Snippet: 2 million of either PC-9 control or PC-9 ERO1A knockout cell line were injected via tail vein into SCID-Beige mice Charles River Laboratories.

Techniques: Western Blot